| 1. |
Kenji Tsuchihashi, Hitomi Sumiyoshi Okuma, Ryunosuke Machida, Ryo Sadachi, Akihiro Hirakawa, Hiroshi Ariyama, Masashi Kanai, Masahisa Kamikura, Kenta Anjo, Akari Hiramitsu, Keisuke Watanabe, Shigeki Sekine, Natsuko Okita, Kenichi Nakamura, Kan Yonemori
, A phase 2 trial of nivolumab monotherapy in rare cancer patients with mismatch repair deficiency or MSI-high: ROCK Trial (NCCH1709) a MASTER KEY sub-study
, 第20回日本臨床腫瘍学会学術集会, 2023.03. |
| 2. |
Kenji Tsuchihashi, Nobuhiro Tsuruta, Hirofumi Ohmura, Kyoko Yamaguchi, Mamoru Ito, kenro Tanoue, Taichi Isobe, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba, PD-L1 expression is regulated by RNA N6-methyladenosine demethylase FTO in colon cancer cells, 第80回 日本癌学会学術集会, 2021.06. |
| 3. |
Kenji Tsuchihashi, Tomoyasu Yoshihiro, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Masato Uenomachi, Mamoru Ito, Kohei Arimizu, Hirofumi Omura, Nobuhiro Tsuruta, Fumiyasu Hanamura, Kyoko Yamaguchi, Taichi Isobe, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba, Eribulin as a first-line treatment for patients with advanced soft tissue sarcoma:a retrospective study, 第17回日本臨床腫瘍学会学術集会, 2019.07. |
| 4. |
Kenji Tsuchihashi, Kenta Nio, Ryosuke Taguchi, Tomoyasu Yoshihiro, Kyoko Yamaguchi, Shohei Moriyama, Mitsuhiro Fukata, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Moe Kondo, Koki Uehara, Shohei Ueno, Masato Uenomachi, Mamoru Ito, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba, Incidence of thromboembolism in patients treated with mutiple kinase inhibitors: a retrospective study, 第17回日本臨床腫瘍学会学術集会, 2019.07. |
| 5. |
Tsuchihashi K, Okazaki S, Yoshikawa M, Seishima R, Sampetrean O, Onishi N, Wakimoto H, Furnari F, Baba E, Akashi K, Saya H, Nagano O, xCT promotes malignant phenotypes in EGFR-expressing glioma , AACR Annual Meeting 2017, 2017.04. |
